Precigen, Inc. (PGEN)
6.85
+0.17
(+2.54%)
USD |
NASDAQ |
Sep 11, 16:00
6.76
-0.09
(-1.31%)
After-Hours: 07:34
Precigen Price to Book Value : 56.28 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 56.28 |
| September 10, 2026 | 54.88 |
| September 09, 2026 | 55.87 |
| September 08, 2026 | 56.44 |
| September 04, 2026 | 58.33 |
| September 03, 2026 | 58.66 |
| September 02, 2026 | 57.59 |
| September 01, 2026 | 56.36 |
| August 31, 2026 | 56.93 |
| August 28, 2026 | 57.10 |
| August 27, 2026 | 59.07 |
| August 26, 2026 | 60.96 |
| August 25, 2026 | 59.81 |
| August 24, 2026 | 58.91 |
| August 21, 2026 | 59.15 |
| August 20, 2026 | 61.12 |
| August 19, 2026 | 58.82 |
| August 18, 2026 | 55.46 |
| August 17, 2026 | 53.81 |
| August 14, 2026 | 50.12 |
| August 13, 2026 | 53.32 |
| August 12, 2026 | 56.28 |
| August 11, 2026 | 56.36 |
| August 10, 2026 | 57.51 |
| August 07, 2026 | 59.40 |
| Date | Value |
|---|---|
| August 06, 2026 | 56.77 |
| August 05, 2026 | 56.61 |
| August 04, 2026 | 53.65 |
| August 03, 2026 | 54.30 |
| July 31, 2026 | 51.51 |
| July 30, 2026 | 48.80 |
| July 29, 2026 | 44.77 |
| July 28, 2026 | 45.43 |
| July 27, 2026 | 44.53 |
| July 24, 2026 | 44.36 |
| July 23, 2026 | 45.51 |
| July 22, 2026 | 43.71 |
| July 21, 2026 | 45.10 |
| July 20, 2026 | 41.65 |
| July 17, 2026 | 40.67 |
| July 16, 2026 | 40.67 |
| July 15, 2026 | 42.06 |
| July 14, 2026 | 42.06 |
| July 13, 2026 | 42.47 |
| July 10, 2026 | 43.71 |
| July 09, 2026 | 45.43 |
| July 08, 2026 | 45.68 |
| July 07, 2026 | 45.27 |
| July 06, 2026 | 46.01 |
| July 02, 2026 | 46.34 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Aldeyra Therapeutics, Inc. | 2.134 |
| Anika Therapeutics, Inc. | 2.034 |
| AC Immune SA | 5.767 |
| Geron Corp. | 3.967 |
| Neurocrine Biosciences, Inc. | 4.297 |
Price to Book Value Related Metrics
| PS Ratio | 28.55 |
| PEG Ratio | -0.0398 |
| Price | 6.85 |
| Earnings Yield | -16.05% |
| Market Cap | 2.452B |
| PEGY Ratio | -0.0398 |